Staurosporine (AM-2282)

For research use only. Not for use in humans.

目录号：S1421 别名： Antibiotic AM-2282, STS 中文名称：星形孢菌素

Staurosporine (AM-2282) Chemical Structure

CAS No. 62996-74-1

Staurosporine (AM-2282, Antibiotic AM-2282, STS)是一种有效的PKC抑制剂，在无细胞试验中作用于PKCα，PKCγ 和PKCη，IC50分别为2 nM，5 nM 和 4 nM，对PKCδ(20 nM)和PKCε(73 nM作用较弱，对PKCζ (1086 nM)的活性很低。同时对其他的激酶PKA, PKG, S6K, CaMKII, 等也显示抑制活性。Phase 3。

规格

价格

库存

购买数量

2mg	RMB 2186.89	现货
5mg	RMB 4095.0	现货
25mg	RMB 12203.1	现货
大包装	有超大折扣

大剂量询单有大折扣!

今日订购，明日送达，全国免运费！

全国免费电话：400-668-6834 | Email：info@selleck.cn

客户使用Selleck生产的Staurosporine (AM-2282)发表文献99篇：

Cell, 2020, 182(3):685-712.e19

PubMed: 32645325 ( click the link to review the publication )

Cancer Discov, 2019, 10.1158/2159-8290.CD-19-0270

PubMed: 31578185 ( click the link to review the publication )

Gastroenterology, 2017, 153(5):1429-1443

PubMed: 28764929 ( click the link to review the publication )

Nat Commun, 2021, 12(1):3636

PubMed: 34140467 ( click the link to review the publication )

Cell Mol Gastroenterol Hepatol, 2021, S2352-345X(21)00196-X

PubMed: 34562639 ( click the link to review the publication )

Cell Chem Biol, 2021, S2451-9456(21)00303-2

PubMed: 34216546 ( click the link to review the publication )

Front Cell Dev Biol, 2021, 9:698679

PubMed: 34195205 ( click the link to review the publication )

Eur J Med Chem, 2021, 211:113003

PubMed: 33248847 ( click the link to review the publication )

Cell Oncol (Dordr), 2021, 10.1007/s13402-021-00632-x

PubMed: 34550531 ( click the link to review the publication )

J Cell Physiol, 2021, 10.1002/jcp.30443

PubMed: 34018605 ( click the link to review the publication )

Molecules, 2021, 26(15)4549

PubMed: 34361708 ( click the link to review the publication )

Biochem Biophys Res Commun, 2021, 567:92-98

PubMed: 34146907 ( click the link to review the publication )

STAR Protoc, 2021, 2(2):100391

PubMed: 33778784 ( click the link to review the publication )

Cell Rep, 2021, 34(8):108767

PubMed: 33626342 ( click the link to review the publication )

J Immunother Cancer, 2021, 9(2)e001906

PubMed: 33526609 ( click the link to review the publication )

EMBO J, 2020, 39(5):e102608

PubMed: 31930741 ( click the link to review the publication )

Genes Dev, 2020, 34(7-8):526-543

PubMed: 32079652 ( click the link to review the publication )

Cell Rep, 2020, 10;30(10):3411-3423 e7

PubMed: 32160546 ( click the link to review the publication )

Cell Rep, 2020, 30(11):3864-3874

PubMed: 32187555 ( click the link to review the publication )

EBioMedicine, 2020, 51:102585

PubMed: 31879244 ( click the link to review the publication )

Sci Signal, 2020, 13(623)

PubMed: 32184287 ( click the link to review the publication )

Cancers (Basel), 2020, 12(9)E2668

PubMed: 32962010 ( click the link to review the publication )

Cancers (Basel), 2020, 10;12(6):E1523

PubMed: 32532053 ( click the link to review the publication )

Anal Chem, 2020, 92(1):1363-1371

PubMed: 31794197 ( click the link to review the publication )
Anal Chem, 2020, 10.1021/acs.analchem.0c02756

PubMed: 32933243 ( click the link to review the publication )

FASEB J, 2020, 34(1):1122-1135

PubMed: 31914633 ( click the link to review the publication )

Eur J Med Chem, 2020, 193:112232

PubMed: 32199135 ( click the link to review the publication )

Nephrol Dial Transplant, 2020, gfaa290

PubMed: 33367746 ( click the link to review the publication )

Eur J Immunol, 2020, 10.1002/eji.202048905

PubMed: 33354776 ( click the link to review the publication )

Int J Mol Sci, 2020, 18;21(8):2825

PubMed: 32325639 ( click the link to review the publication )

Sci Rep, 2020, 10(1):18677

PubMed: 33122816 ( click the link to review the publication )

Sci Rep, 2020, 10(1):931

PubMed: 31969633 ( click the link to review the publication )

Molecules, 2020, 25(18)E4318

PubMed: 32967084 ( click the link to review the publication )

Eur J Pharmacol, 2020, 868:172886

PubMed: 31866407 ( click the link to review the publication )

Neoplasia, 2020, 22(10):470-483

PubMed: 32818841 ( click the link to review the publication )

Cell Res, 2020, 1-13

PubMed: 32759968 ( click the link to review the publication )

Cell Rep, 2020, 32(4):107959

PubMed: 32726624 ( click the link to review the publication )

Oncogene, 2020, 10.1038/s41388-020-1382-5

PubMed: 32651460 ( click the link to review the publication )

Mol Cancer Ther, 2020, 19(2):637-649

PubMed: 31784455 ( click the link to review the publication )

Autophagy, 2019, 10.1080/15548627

PubMed: 31251111 ( click the link to review the publication )

Autophagy, 2019, 15(2):295-311

PubMed: 30176161 ( click the link to review the publication )

Br J Pharmacol, 2019, 176(22):4388-4401

PubMed: 30270436 ( click the link to review the publication )

Ther Adv Med Oncol, 2019, 11:1758835919891567

PubMed: 31839810 ( click the link to review the publication )

FASEB J, 2019, 33(8):9062-9074

PubMed: 31180722 ( click the link to review the publication )

Nephrol Dial Transplant, 2019, 34(6):934-941

PubMed: 30189026 ( click the link to review the publication )

Int J Biol Sci, 2019, 15(4):838-846

PubMed: 30906214 ( click the link to review the publication )

Int Immunopharmacol, 2019, 66:146-153

PubMed: 30453148 ( click the link to review the publication )

Methods Mol Biol, 2019, 2054:171-183

PubMed: 31482456 ( click the link to review the publication )
J Org Chem, 2019, 10.1021/acs.joc.9b02414

PubMed: 31858795 ( click the link to review the publication )

Cell Res, 2018, 28(8):833-854

PubMed: 30030520 ( click the link to review the publication )

Nat Commun, 2018, 9(1):4846

PubMed: 30451870 ( click the link to review the publication )

Oncogene, 2018, 37(30):4122-4136

PubMed: 29706657 ( click the link to review the publication )

Oncogene, 2018, 37(11):1485-1502

PubMed: 29321664 ( click the link to review the publication )

Arch Toxicol, 2018, 92(6):2119-2135

PubMed: 29589053 ( click the link to review the publication )

Biochem Pharmacol, 2018, 150:9-23

PubMed: 29338970 ( click the link to review the publication )

Acta Pharmacol Sin, 2018, 39(12):1902-1912

PubMed: 30038340 ( click the link to review the publication )

Analyst, 2018, 143(12):2908-2914

PubMed: 29808847 ( click the link to review the publication )

Mol Carcinog, 2018, 57(7):886-895

PubMed: 29566278 ( click the link to review the publication )

Phytomedicine, 2018, 40:148-157

PubMed: 29496167 ( click the link to review the publication )

Exp Cell Res, 2018, 370(1):103-115

PubMed: 29908160 ( click the link to review the publication )

Virus Res, 2018, 246:55-64

PubMed: 29341877 ( click the link to review the publication )

J Child Adolesc Psychopharmacol, 2018, 28(2):117-123

PubMed: 29161523 ( click the link to review the publication )

Oncotarget, 2018, 9(24):16917-16931

PubMed: 29682194 ( click the link to review the publication )

Oncotarget, 2018, 9(89):35962-35973

PubMed: 30542510 ( click the link to review the publication )

Oncotarget, 2018, 9(32):22254-22268

PubMed: 29854276 ( click the link to review the publication )

Nat Commun, 2017, 1;8(1):1232

PubMed: 29089541 ( click the link to review the publication )

EMBO J, 2017, 36(2):202-212

PubMed: 27852626 ( click the link to review the publication )

Cell Rep, 2017, 20(7):1692-1704

PubMed: 28813679 ( click the link to review the publication )

Anal Chem, 2017, 89(3):1892-1899

PubMed: 28208281 ( click the link to review the publication )

Mol Cancer Ther, 2017, 16(1):57-67

PubMed: 27760835 ( click the link to review the publication )

Mol Cancer Ther, 2017, 16(10):2201-2214

PubMed: 28619755 ( click the link to review the publication )

J Virol, 2017, 91(23)

PubMed: 28904196 ( click the link to review the publication )
Acta Pharmacol Sin, 2017, 38(12):1632-1641

PubMed: 28713162 ( click the link to review the publication )

J Agric Food Chem, 2017, 65(31):6625-6637

PubMed: 28697598 ( click the link to review the publication )

Virology, 2017, 505:91-101

PubMed: 28235685 ( click the link to review the publication )

SLAS Discov, 2017, 22(5):507-515

PubMed: 28324660 ( click the link to review the publication )

Oncotarget, 2017, 8(42):71512-71519

PubMed: 29069723 ( click the link to review the publication )

Eur J Med Chem, 2016, 124:583-607

PubMed: 27614407 ( click the link to review the publication )

Mol Pharm, 2016, 13(11):3724-3735

PubMed: 27653969 ( click the link to review the publication )

J Cancer Res Clin Oncol, 2016, 142(11):2263-73

PubMed: 27576506 ( click the link to review the publication )

PLoS One, 2016, 11(5):e0154932

PubMed: 27183222 ( click the link to review the publication )

Biochem Biophys Res Commun, 2016, 471(4):528-32

PubMed: 26879140 ( click the link to review the publication )

Exp Clin Endocrinol Diabetes, 2016, 1427:419-30

PubMed: 26849668 ( click the link to review the publication )

Oncotarget, 2016, 7(46):74987-74999

PubMed: 27602492 ( click the link to review the publication )

Oncotarget, 2016, 7(27):41488-41504

PubMed: 27166192 ( click the link to review the publication )

Methods Mol Biol, 2016, 1427:419-30

PubMed: 27259939 ( click the link to review the publication )

Mol Cancer, 2015, 14:114

PubMed: 26041471 ( click the link to review the publication )

Mol Cancer, 2015, 14:59

PubMed: 25880778 ( click the link to review the publication )

J Exp Clin Cancer Res, 2015, 34:69

PubMed: 26198850 ( click the link to review the publication )

Cancer Cell Int, 2015, 15:97

PubMed: 26464561 ( click the link to review the publication )

PLoS One, 2015, 10(3):e0119715

PubMed: 25790461 ( click the link to review the publication )

PLoS One, 2015, 10(7):e0134306

PubMed: 26218638 ( click the link to review the publication )

Cancer Res, 2014, 74(23):7090-102

PubMed: 25277525 ( click the link to review the publication )

Cell Rep, 2014, 8(4):1037-48

PubMed: 25127139 ( click the link to review the publication )

Cell Commun Signal, 2013, 11:76

PubMed: 24090154 ( click the link to review the publication )

Am J Physiol Cell Physiol, 2013, 304(9):C895-904

PubMed: 23447036 ( click the link to review the publication )
J Biomol Screen, 2013, 18(4):388-99

PubMed: 23134735 ( click the link to review the publication )

PLoS One, 2012, 7(6):e39679

PubMed: 22768106 ( click the link to review the publication )

J Biomol Screen, 2012, 17(6):813-21

PubMed: 22453235 ( click the link to review the publication )

产品安全说明书

Antineoplastic and Immunosuppressive Antibiotics抑制剂选择性比较

生物活性

产品描述

靶点

PKCα ^[1] (Cell-free assay)	c-Fgr ^[2] (Cell-free assay)	phosphorylase kinase ^[2] (Cell-free assay)	PKCη ^[1] (Cell-free assay)	PKCγ ^[1] (Cell-free assay)	点击更多
2 nM	2 nM	3 nM	4 nM	5 nM	点击更多

体外研究

Staurosporine 也强抑制HeLa S3细胞，IC50为4 nM。^[1]Staurosporine 也抑制多种其他蛋白激酶，包括PKA, PKG, 磷酸激酶, S6 激酶, 肌球蛋白轻链激酶(MLCK), CAM PKII, cdc2, v-Src, Lyn, c-Fgr, 和Syk ， IC50分别为 15 nM, 18 nM, 3 nM, 5 nM, 21 nM, 20 nM, 9 nM, 6 nM, 20 nM, 2 nM, 和 16 nM。^[3] Staurosporine (1 μM) 诱导 PC12细胞90%以上凋亡,这种作用可被过量表达的Bcl-2抑制,或者zVAD-fmk, cycloheximide (10 μM) 及actinomycin D (5 μM)处理也可抑制。相应地, Staurosporine处理，诱导细胞内游离钙水平 [Ca²⁺]_i快速且持久的提升，线粒体活性氧（ROS）的积累,及随后的线粒体功能障碍。^[4]通过caspase-8激活和Bid 分裂，功能性caspase-3的表达可增强Staurosporine诱导MCF7细胞死亡。^[5] 1 μM Staurosporine处理，只部分抑制IL-3刺激的Bcl2 磷酸化，而完全阻断PKC调节的 Bcl2磷酸化。^[6] Staurosporine 诱导人类包皮成纤维细胞AG-1518凋亡,根据溶酶体组织蛋白酶D调节的细胞色素 c释放和 caspase 激活。^[7] 除了激活传统线粒体凋亡通路, Staurosporine触发一种新型内在凋亡通路, 依赖Apaf-1存在时对caspase-9的激活。^[8]

Cell Data

Cell Lines	Assay Type	Concentration	Incubation Time	Activity Description	PMID
human colon carcinoma cell line HCT116	NXvKVGJbTnWwY4Tpc44h[XO\|YYm=			MoHpR49v[2WwdILheIlwdiC{ZYH1bZJm\CCob4Kg[5Jwf3SqIHnubIljcXSrb36gc4YhcHWvYX6gZ49td25iY3HyZ4lvd22jIHPlcIwhdGmwZTDIR3QyOTZuIFnDOVA:PiCwTT6=	NHH2blk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUWzO\|M1PSd-MUW1N\|c{PDV:L3G+
human PBMC	NG\Gd3NHfW6ldHnvckBie3OjeR?=		MmDCNlQhcA>?	M37vWnN2eHC{ZYPzbY9vKG:oIFnMNkBxem:mdXP0bY9vKGmwIHj1cYFvKFCETVOgZYZ1\XJiMkSgbJJ{KGK7IFXMTXNCNCCLQ{WwQVE3KG6PLh?=	NHLBOok9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOEW4OVA1Pid-MUi1PFUxPDZ:L3G+
endothelial cells	MnzlSpVv[3Srb36gZZN{[Xl?			NVvZ[XNNTW[oZXP0bZZmKGSxc3WgZYdicW6\|dDDwcIF{dWmwb3flckBi[3SrdnH0c5Ih[WO2aY\peJkhe3SrbYXsZZRm\CCkeTDwbI9z[m:uIHXzeIVzKGmwIHXu[I91cGWuaXHsJINmdGy\|LDDFSFUxKD1iNz61JO69VS5?	NE[0ZYk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi96N{C5NFk2Lz56N{C5NFk2RC:jPh?=
Sf9 insect cells	MYDGeY5kfGmxbjDhd5NigQ>?			MXPJcohq[mm2aX;uJI9nKHC{b4TlbY4hc2mwYYPlJGMpOTpzbXn4eJVz\SCxZjDQT2Mh[WyyaHGgKkBj\XSjKTDlfJBz\XO\|ZXSgbY4hW2Z7IHnud4VkfCClZXzsd{whUUN3MDC9JFAvODJizszNMi=>	M4DLfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493Nzl6N{O2NFUoRjl6N{O2NFU9N2F-
LoVo cells	NH:5bGtCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBie3OjeR?=			MYLBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKGOxbH;uJINidmOncjDj[YxtKGyrbnWgLGxwXm9iY3XscJMqKHW\|aX7nJG1VXCCjc4PhfUwhUUN3MDC9JFAvODBzIN88UU4>	NWHpWWdPRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUG1PVE2ODVpPkGxOVkyPTB3PD;hQi=>
umbilical vein endothelial cells	M3PYUWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIF{e2G7			NH7pSHpCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIIXtZoltcWOjbDD2[YlvKGWwZH;0bIVtcWGuIHPlcIx{KCiKVW\FR5MqKHW\|aX7nJG1VXCCjc4PhfUwhUUN3MDC9JFAvODB2IN88UU4>	NV\Ee\|kyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUG1PVE2ODVpPkGxOVkyPTB3PD;hQi=>
ST-486 cells	M13CcmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIF{e2G7			MXjBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHL1dotqfCCueX3wbI9u[SClZXzsJIxqdmViKGPUMVQ5PiClZXzsd{khfXOrbnegUXRVKGG\|c3H5MEBKSzVyIE2gNE4xODdizszNMi=>	MVW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yOTV7MUWwOUc,OTF3OUG1NFU9N2F-
DLD-1 cells	MYTBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDhd5NigQ>?			NVf0VIdvSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDjc4xwdiClYX7j[ZIh[2WubDDsbY5mKCiGTFStNUBk\WyuczmgeZNqdmdiTWTUJIF{e2G7LDDJR\|UxKD1iMD6wNFkh\|ryPLh?=	M4\tdFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzFzNUmxOVA2Lz5zMUW5NVUxPTxxYU6=
HEK293 cells	MlvXSpVv[3Srb36gZZN{[Xl?			MYjJcohq[mm2aX;uJI9nKFCNQz3i[ZRiKEmLIH3l[IlifGWmIFnMMVghemWuZXHz[UBnem:vIFjFT\|I6OyClZXzsd{BjgSCHTFnTRUwhUUN3MDC9JFAvODd5IN88UU4>	NFT4c4Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zMkm0NVM{OSd-MUK5OFE{OzF:L3G+
P19 cells	NYTjdpJoTnWwY4Tpc44h[XO\|YYm=			NXr4cWF6UW6qaXLpeIlwdiCxZjDQcIF1\WyndD3k[ZJqfmWmIHfyc5d1cCCoYXP0c5IhemWlZYD0c5IhcW5iUEG5JINmdGy\|LDDJR\|UxKD1iMD6wNFIh\|ryPLh?=	MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTd5MUSxPUc,OTV5N{G0NVk9N2F-
P19 cells	NUfsWW9wTnWwY4Tpc44h[XO\|YYm=			NXX1dY1rUW6qaXLpeIlwdiCxZjDQcIF1\WyndD3k[ZJqfmWmIHfyc5d1cCCoYXP0c5IhemWlZYD0c5IhcW5iUEG5JINmdGy\|LDDJR\|UxKD1iMD6wNFIh\|ryPLh?=	NYLy[o1ORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW3O\|E1OTlpPkG1O\|cyPDF7PD;hQi=>
P19 cells	Mn\NSpVv[3Srb36gZZN{[Xl?			NIS0cHRKdmirYnn0bY9vKG:oIGDyc5RmcW5iS3nuZZNmKEFiaX6gVFE6KGOnbHzzMEBKSzVyIE2gNE4xODRizszNMi=>	M3nlZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3N{exOFE6Lz5zNUe3NVQyQTxxYU6=
P19 cells	NWD2NXJpTnWwY4Tpc44h[XO\|YYm=			NFr2bnVKdmirYnn0bY9vKG:oIFPhcINqfW1xY3HscY9lfWyrbj3k[ZBmdmSnboSgdJJwfGWrbjDrbY5ie2VidInw[UBKUSCrbjDQNVkh[2WubIOsJGlEPTBiPTCwMlAxPiEQvF2u	M{C5OlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3N{exOFE6Lz5zNUe3NVQyQTxxYU6=
P19 cells	MUfGeY5kfGmxbjDhd5NigQ>?			NVPUOoF5UW6qaXLpeIlwdiCxZjDDfYNtcW5vZHXw[Y5l\W62IHvpcoF{\SBzIHnuJHAyQSClZXzsd{whUUN3MDC9JFAvODB6IN88UU4>	NUnLeVA6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW3O\|E1OTlpPkG1O\|cyPDF7PD;hQi=>
P19 cells	MUXGeY5kfGmxbjDhd5NigQ>?			M3faU2lvcGmkaYTpc44hd2ZiVnHzZ5Vt[XJiZX7kc5Rp\WyrYXyg[5Jwf3SqIH\hZ5RweiC{ZXPldJRweiCrbjDQNVkh[2WubIOsJGlEPTBiPTCwMlAyPCEQvF2u	MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTd5MUSxPUc,OTV5N{G0NVk9N2F-
HEK293 cells	MoXiSpVv[3Srb36gZZN{[Xl?			M4ew[mlvcGmkaYTpc44hd2ZiSVytPEBz\WynYYPlJIJ6KEiHS{K5N{Bk\WyuczDlfJBz\XO\|aX7nJHBMSy2kZYThNkwhUUN3MDC9JFAvODd5IN88UU4>	NUmye2F5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW3O\|E1OTlpPkG1O\|cyPDF7PD;hQi=>
P19 cells	NYC0[ZpzTnWwY4Tpc44h[XO\|YYm=			MXvJcohq[mm2aX;uJI9nKEmwc4XsbY4hemWlZYD0c5Ihc2mwYYPlJIlvKFBzOTDj[YxteyxiSVO1NEA:KDBwMjFOwG0v	MkSyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV5N{G0NVkoRjF3N{exOFE6RC:jPh?=
P19 cells	MXnGeY5kfGmxbjDhd5NigQ>?			NUTkT2xRUW6qaXLpeIlwdiCxZjDDZZNmcW5ia3nuZZNmKDFiaX6gVFE6KGOnbHzzMEBKSzVyIE2gNU41KM7:TT6=	NHjvNWs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUe3NVQyQSd-MUW3O\|E1OTl:L3G+
FL5.12-Akt1 cells	M1W2O2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIF{e2G7			NIXUOldCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JGZNPS5zMj3Bb5QyKGOnbHzzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDBwMkmg{txONg>?	MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPjRyM{[yOkc,OTZ2MEO2NlY9N2F-
MiaPaCa-2 cells	NGT0WJpCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBie3OjeR?=			M{PKOGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgUYliWGGFYT2yJINmdGy\|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFAvOzdizszNMi=>	MlezQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTZ2MEO2NlYoRjF4NECzOlI3RC:jPh?=
FL5.12-Akt1 cells	MnLOSpVv[3Srb36gZZN{[Xl?			MljDRYN1cX[rdImgZYdicW6\|dDDHV2s{KGmwIF\MOU4yOi2Da4SxJINmdGy\|LDDFR\|UxKD1iMD60OkDPxE1w	NYTpRoRIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMU[0NFM3OjZpPkG2OFA{PjJ4PD;hQi=>
MiaPaCa-2 cells	NFLYfIJCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBie3OjeR?=			NIDhTFNCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3pZXBiS2FvMjDj[YxteyxiSVO1NEA:KDBwM{eg{txONg>?	NWfVc\|d4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMU[0NVM4QDBpPkG2OFE{PzhyPD;hQi=>
FL5.12-Akt1 cells	NYrrcY51TnWwY4Tpc44h[XO\|YYm=			MVrBZ5Rqfmm2eTDh[4FqdnO2IFfTT\|MheGixc4Doc5J6dGG2aX;uJIlvKE[ONT6xNk1Cc3RzIHPlcIx{NCCHQ{WwJF0hOC52NjFOwG0v	MlvkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTZ2MUO3PFAoRjF4NEGzO\|gxRC:jPh?=
Sf21 cells	M1TteWZ2dmO2aX;uJIF{e2G7			Ml\ZTY5pcWKrdHnvckBw\iCMQVuzJIV5eHKnc4Pl[EBqdiCVZkKxJINmdGy\|LDDJR\|UxKD1iMD6wNFYh\|ryPLh?=	MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzB6OEC1PUc,OTdyOEiwOVk9N2F-
U937 cells	M4n6UmN6fG:2b4jpZ4l1gSCjc4PhfS=>			MkDZR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gWVk{PyClZXzsd{whUUN3MDC9JFIh\|ryPLh?=	NIexdoQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{C4PFA3Pyd-MUewPFgxPjd:L3G+
Sf9 cells	NVrVVI8xTnWwY4Tpc44h[XO\|YYm=		NUOyfVRlOSCvaX6=	NIXFd\|dKdmirYnn0bY9vKG:oIHj1cYFvKE[7bjDlfJBz\XO\|ZXSgbY4hW2Z7IHPlcIx{KGGodHXyJFEhdWmwIHL5JGVNUVODIHnuJJBz\XOnbnPlJI9nKDFidX3vcE9NKEGWUDygTWM2OCB;IECuNFA2KM7:TT6=	M{HlfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5M{G1PFU{Lz5zN{OxOVg2OzxxYU6=
Sf9 cells	MXHGeY5kfGmxbjDhd5NigQ>?		NVzGNoZnOjBibXnudy=>	MlnyTY5pcWKrdHnvckBw\iCqdX3hckBHgW5iZYjwdoV{e2WmIHnuJHNnQSClZXzsd{Bi\nSncjCyNEBucW6\|IHL5JGVNUVODIHnuJJBz\XOnbnPlJI9nKDFidX3vcE9NKEGWUDygTWM2OCB;IECuNFE2KM7:TT6=	NWLXd4VCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUezNVU5PTNpPkG3N\|E2QDV\|PD;hQi=>
Sf9 cells	MWHGeY5kfGmxbjDhd5NigQ>?		NUL0cVFyOSCvaX6=	MlHnTY5pcWKrdHnvckBw\iCqdX3hckBHgW5iZYjwdoV{e2WmIHnuJHNnQSClZXzsd{Bi\nSncjCxJI1qdiCkeTDFUGlUSSCrbjDwdoV{\W6lZTDv[kAyOCC3bX;sM2whSVSSLDDJR\|UxKD1iMD6wN\|Yh\|ryPLh?=	MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzNzNUi1N{c,OTd\|MUW4OVM9N2F-
Sf9 cells	MX;GeY5kfGmxbjDhd5NigQ>?		MlnoNlAhdWmwcx?=	NYG2XZl5UW6qaXLpeIlwdiCxZjDoeY1idiCIeX6g[ZhxemW\|c3XkJIlvKFOoOTDj[YxteyCjZoTldkAzOCCvaX7zJIJ6KEWOSWPBJIlvKHC{ZYPlcoNmKG:oIEGwJJVud2xxTDDBWHAtKEmFNUCgQUAxNjB6MzFOwG0v	NFj1fWk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{OxOVg2Oyd-MUezNVU5PTN:L3G+
Sf9 cells	NUO2NoFITnWwY4Tpc44h[XO\|YYm=		MW[xJI1qdg>?	NGDQXWFKdmirYnn0bY9vKG:oIHj1cYFvKE[7bjDlfJBz\XO\|ZXSgbY4hW2Z7IHPlcIx{KGGodHXyJFEhdWmwIHL5JGVNUVODIHnuJJBz\XOnbnPlJI9nKDFyMDD1cY9tN0xiQWTQMEBKSzVyIE2gNE4zPyEQvF2u	NHHVUpg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{OxOVg2Oyd-MUezNVU5PTN:L3G+
Sf9 cells	M2\qWWZ2dmO2aX;uJIF{e2G7		M1[yV\|IxKG2rboO=	MkPPTY5pcWKrdHnvckBw\iCqdX3hckBHgW5iZYjwdoV{e2WmIHnuJHNnQSClZXzsd{Bi\nSncjCyNEBucW6\|IHL5JGVNUVODIHnuJJBz\XOnbnPlJI9nKDFyMDD1cY9tN0xiQWTQMEBKSzVyIE2gNE42OSEQvF2u	MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzNzNUi1N{c,OTd\|MUW4OVM9N2F-
A549 cells	M37QNGN6fG:2b4jpZ4l1gSCjc4PhfS=>		MVy3NkBp	MnnjR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVU1QSClZXzsd{Bi\nSncjC3NkBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDt[ZRpd2RuIFfJOVAhRSByLkCwNlQh\|ryPLh?=	NH:4N2g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOES4OFc4PSd-MUi0PFQ4PzV:L3G+
MDA-MB-231 cells	NGDHdVJEgXSxdH;4bYNqfHliYYPzZZk>		NV7YUXQ4PzJiaB?=	MV3DfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDNSGEuVUJvMkOxJINmdGy\|IHHmeIVzKDd{IHjyd{BjgSC\|dXzmc5Jpd2SjbXnu[UBDKG2ndHjv[EwhT0l3MDC9JFAvODB5MTFOwG0v	M2nF[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NEi0O\|c2Lz5zOES4OFc4PTxxYU6=
HT29 cells	MXLDfZRwfG:6aXPpeJkh[XO\|YYm=		M160TFczKGh?	NUXzNpVWS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUFR{OTDj[YxteyCjZoTldkA4OiCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBu\XSqb3SsJGdKPTBiPTCwMlAyODlizszNMi=>	M1juNFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NEi0O\|c2Lz5zOES4OFc4PTxxYU6=
MCF7 cells	M3ToSmZ2dmO2aX;uJIF{e2G7			MkS3TY5pcWKrdHnvckBw\iCSS1GgbY4hcHWvYX6gUWNHPyClZXzsd{BjgSCjcoLhfU1j[XOnZDDmcJVwemW\|Y3XuZ4Uh[XO\|YYmsJGtqKD1iMD6wNFUh\|ryPLh?=	MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDZ3NkO2PUc,OTh4NU[zOlk9N2F-
MCF7 cells	MV\GeY5kfGmxbjDhd5NigQ>?			MoLZTY5pcWKrdHnvckBw\iCSS1GgbY4hcHWvYX6gUWNHPyClZXzsd{BjgSCjcoLhfU1j[XOnZDDmcJVwemW\|Y3XuZ4Uh[XO\|YYmsJGlEPTBiPTCyJO69VS5?	NVTieHZLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi2OVY{PjlpPkG4OlU3OzZ7PD;hQi=>
Sf9 cells	MkD0SpVv[3Srb36gZZN{[Xl?			M4Hj[2lvcGmkaYTpc44hd2ZiaIXtZY4hW3mtIHX4dJJme3OnZDDpckBU\jliY3XscJMtKEmFNUCgQUAxNjByMzFOwG0v	NHjHUGg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOEiyN\|c5PCd-MUi4NlM4QDR:L3G+
Sf9 cells	M{LUbWZ2dmO2aX;uJIF{e2G7			M2qyRmlvcGmkaYTpc44hd2ZiaIXtZY4hYkGSN{Cg[ZhxemW\|c3XkJIlvKFOoOTDj[YxteyxiSVO1NEA:KDBwMEWzJO69VS5?	NGP0eG49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOEiyN\|c5PCd-MUi4NlM4QDR:L3G+
insect cells	NV\ZVnRuTnWwY4Tpc44h[XO\|YYm=			NVSy[3RNUW6qaXLpeIlwdiCxZjDoeY1idiC{ZXPvcYJqdmGwdDDQbY0yKGW6cILld5Nm\CCrbjDpcpNm[3RiY3XscJMh[nliSGTSSkwhUUN3MDC9JFAvODFizszNMi=>	NGH3V4Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUG3PVA4Pid-MUmxO\|kxPzZ:L3G+
HT-29 cells	NX;UdXpjSXCxcITvd4l{KGG\|c3H5		NHfOUHczKGh?	MVPJcoR2[3Srb36gc4Yh[XCxcITvd4l{KGmwIHj1cYFvKEiWLUK5JINmdGy\|IHHzd4V{e2WmIHHzJINp[W6pZTDpckBucXSxY3jvcoRzcWGuIITyZY5{dWWvYoLhcoUheG:2ZX70bYFtKGGodHXyJFIhcHK\|IHL5JGpEOSC\|dHHpcolv\yCkYYPl[EBndHWxcnXzZ4Vv[2ViYYPzZZktKEWGNUCgQUAxNjByMk[g{txONg>?	NUnhbWVsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm0NlIzODZpPkG5OFIzOjB4PD;hQi=>
insect Sf21 cells	M{PFbWZ2dmO2aX;uJIF{e2G7			NXPJc3R1UW6qaXLpeIlwdiCxZjDKRWs{KGW6cILld5Nm\CCrbjDpcpNm[3RiU3[yNUBk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIHLpc5RqdnmuYYTl[EB{fWK\|dILheIUheGixc4Doc5J6dGG2aX;uMEBKSzVyIE2gNE4xODZizszNMi=>	MkDwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl2MkeyNFMoRjF7NEK3NlA{RC:jPh?=
Jurkat cells	M{DaVmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIF{e2G7			MWDBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IFrBT\|Mh\XiycnXzd4lv\yCLTEKtd5RqdXWuYYTl[EBpfW2jbjDKeZJs[XRiY3XscJMtKEmFNUCgQUAxNjB5MTFOwG0v	MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTR{N{KwN{c,OTl2MkeyNFM9N2F-
Jurkat cells	M1yxXmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIF{e2G7			MYPBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IFrBT\|Mh\XiycnXzd4lv\yCqdX3hckBz\XO2aX7nJGp2emujdDDj[YxteyxiSVO1NEA:KDBwM{GxJO69VS5?	NEP1[\|E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUSyO\|IxOyd-MUm0NlczODN:L3G+
HUE cells	MljLSpVv[3Srb36gZZN{[Xl?		NXO5W2RMQTBibXnudy=>	NYH1TmxNUW6qaXLpeIlwdiCxZjDWSWdHWjJiaX6gTHVGKGOnbHzzJIF{e2W\|c3XkJIF{KGmwaHnibZRqd25ib3[gWmVITi2rbnT1Z4VlKGG3dH;wbI9{eGixconsZZRqd25idILlZZRm\CCob4KgPVAhdWmwczDi[YZwemViVlXHSkBkcGGubHXu[4Uh[nliRVzJV2EtKEmFNUCgQUAxNjB5IN88UU4>	NEPuZ2w9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEG3NFE3Oyd-MkCxO\|AyPjN:L3G+
Sf9 cells	NXj6N\|luTnWwY4Tpc44h[XO\|YYm=		NHrEbm03OCCvaX7z	MX7Jcohq[mm2aX;uJI9nKGi3bXHuJJJm[2:vYnnuZY51KEeVVD3meZNm\CCQSVug[ZhxemW\|c3XkJIlvKFOoOTDj[YxteyCjZoTldkA3OCCvaX7zJIJ6KHKjZHnvcYV1emmlIIDyc5RmcW5ia3nuZZNmKGG\|c3H5MEBKSzVyIE2gNk4{KM7:TT6=	MknaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjB3OEC1OVIoRjJyNUiwOVUzRC:jPh?=
Sf21 cells	M{XTN2Z2dmO2aX;uJIF{e2G7	NF7POHY{OCC3TR?=		NWTIdZZyUW6qaXLpeIlwdiCxZjDoeY1idiCFSFuyJItqdmG\|ZTDlfJBz\XO\|ZXSgbY4hcW6\|ZXP0JHNnOjFiY3XscJMhfXOrbnegdIhwe3Cqbz3DVmVDfGmmZTDhd{B{fWK\|dILheIUh[XRiM{CgeW0tKEmFNUCgQUAxNjB{NzFOwG0v	M1e1NFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzM{O0O\|k3Lz5{MUOzOFc6PjxxYU6=
Sf21 cells	NVLYTVJmTnWwY4Tpc44h[XO\|YYm=	NXzRW3NFOzBidV2=		NHHXdohKdmirYnn0bY9vKG:oIHj1cYFvKHKnY3;tZolv[W62IFnLT{1idHCqYTDlfJBz\XO\|ZXSgbY4hcW6\|ZXP0JHNnOjFiY3XscJMhfXOrbnegdIhwe3Cqbz3VcIlocHRvSXvhdJBiSi2jbIDoZUBieyC\|dXLzeJJifGViYYSgN\|AhfU1uIFnDOVAhRSByLkCzPUDPxE1w	NHj6NIM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUOzOFc6Pid-MkGzN\|Q4QTZ:L3G+
Sf21 cells	MlX4SpVv[3Srb36gZZN{[Xl?	MnjaN\|AhfU1?		MX7Jcohq[mm2aX;uJI9nKGi3bXHuJJJm[2:vYnnuZY51KEmNSz3i[ZRiKGW6cILld5Nm\CCrbjDpcpNm[3RiU3[yNUBk\WyuczD1d4lv\yCyaH;zdIhwNVWuaXfoeE1Kc2GycHHCMYFteGijIHHzJJN2[nO2cnH0[UBifCB\|MDD1UUwhUUN3MDC9JFAvPDlizszNMi=>	M1P1W\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzM{O0O\|k3Lz5{MUOzOFc6PjxxYU6=
HeLa cells	NET2PIFEgXSxdH;4bYNqfHliYYPzZZk>		M3uxeVQ5KGh?	MoqzR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gTIVN[SClZXzsd{Bi\nSncjC0PEBpenNiYomgUXRVKGG\|c3H5MEBKSzVyIE2gNE4xODByMESg{txONg>?	MkG3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF\|OEixPVEoRjJzM{i4NVkyRC:jPh?=
MCF7 cells	NFfzNG5EgXSxdH;4bYNqfHliYYPzZZk>		M1rSclQ5KGh?	NFn1bVREgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBOS0Z5IHPlcIx{KGGodHXyJFQ5KGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAxNjB3IN88UU4>	Mkf3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF\|OEixPVEoRjJzM{i4NVkyRC:jPh?=
HT-29 cells	M3fLemZ2dmO2aX;uJIF{e2G7		M1PpSFIhcA>?	MVTF[oZm[3Rib36gcYl1d2Oqb37kdolidCCvZX3idoFv\SCyb4TlcpRq[WxiaX6gbJVu[W5iSGStNlkh[2WubIOgZYZ1\XJiMjDodpMhfXOrbnegTmMuOSC\|dHHpcolv\yCkeTDmcJVwemW\|Y3XuZ4Uh[XO\|YYmsJGlEPTBiPTCwMlAxOiEQvF2u	NYTKS2R2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0Nlg{PzVpPkKxOFI5Ozd3PD;hQi=>
HeLa cells	M3vQd2N6fG:2b4jpZ4l1gSCjc4PhfS=>		MX:0PEBp	NVTic\|ZHS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUGWOYTDj[YxteyCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOC5yMECwNFQh\|ryPLh?=	NWrxfpdGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0PFg3PTVpPkKxOFg5PjV3PD;hQi=>
MCF7 cells	NU\KfVNQS3m2b4TvfIlkcXS7IHHzd4F6		MVu0PEBp	M1HQdGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJG1ETjdiY3XscJMh[W[2ZYKgOFghcHK\|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFAvODVizszNMi=>	MnfHQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2OEi2OVUoRjJzNEi4OlU2RC:jPh?=
HT-29 cells	M2DiPGZ2dmO2aX;uJIF{e2G7			MlPqTY5pcWKrdHnvckBw\iCvaYTvZ4hwdmS{aXHsJI1mdWK{YX7lJJBwfGWwdHnhcEBqdiCqdX3hckBJXC1{OTDj[YxteyC3c3nu[{BLSzFiZInlJJN1[WmwaX7nJIJ6KG[udX;y[ZNk\W6lZTDwcIF1\SC{ZXHk[ZIh[XO\|YYmsJGlEPTBiPTCwMlAxOjVizszNMi=>	MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTVzM{K5N{c,OjF3MUOyPVM9N2F-
SF268 cells	NEXH[\|VEgXSxdH;4bYNqfHliYYPzZZk>		MnfLOFghcA>?	NH\QV4pEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBUTjJ4ODDj[YxteyCjZoTldkA1QCCqcoOgZpkhW1KEIHHzd4F6NCCJSUWwJF0hOC5yNESg{txONg>?	NInmUGs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUWxN\|I6PCd-MkG1NVMzQTR:L3G+
CHOK1 cells	M3qx[WN6fG:2b4jpZ4l1gSCjc4PhfS=>		M1K3blQ5KGh?	MYPDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDDTG9MOSClZXzsd{Bi\nSncjC0PEBpenNiYomgV3JDKGG\|c3H5MEBIUTVyIE2gNE4yOyEQvF2u	MnfaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF3MUOyPVQoRjJzNUGzNlk1RC:jPh?=
H460 cells	MWrDfZRwfG:6aXPpeJkh[XO\|YYm=		MnXXOFghcA>?	M1PoU2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGg1PjBiY3XscJMh[W[2ZYKgOFghcHK\|IHL5JHNTSiCjc4PhfUwhT0l3MDC9JFMvPiEQvF2u	MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTVzM{K5OEc,OjF3MUOyPVQ9N2F-
HT-29 cells	NXvkeVlHS3m2b4TvfIlkcXS7IHHzd4F6		NXHEbHE6PDhiaB?=	NYH3dppJS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUFRvMkmgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KFOUQjDhd5NigSxiR1m1NEA:KDNwNjFOwG0v	MkPSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF3MUOyPVQoRjJzNUGzNlk1RC:jPh?=
MCF7 cells	M4f1WWN6fG:2b4jpZ4l1gSCjc4PhfS=>		MX60PEBp	MmftR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUWNHPyClZXzsd{Bi\nSncjC0PEBpenNiYomgV3JDKGG\|c3H5MEBIUTVyIE2gNVEh\|ryPLh?=	NXfOWY1XRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG1NVMzQTRpPkKxOVE{Ojl2PD;hQi=>
SW1116 cells	M4nSemZ2dmO2aX;uJIF{e2G7		Mn3hNlQhcA>?	MWHJcohq[mm2aX;uJI9nKHSnbH;t[ZJie2ViaX6gbJVu[W5iU2exNVE3KGOnbHzzJIFnfGW{IEK0JIhzeyCkeTDUVmFRNVCFUj3FUGlUSSCjc4PhfUwhUUN3MDC9JFgvOzJizszNMi=>	NETJPI49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUm2NlUzOyd-MkG5OlI2OjN:L3G+
HT-29 cells	MYrBdI9xfG:\|aYOgZZN{[Xl?		NIq0VGQzKGh?	MYLJcoR2[3Srb36gc4Yh[XCxcITvd4l{KGmwIHj1cYFvKEiWLUK5JINmdGy\|IHHzd4V{e2WmIILl[JVkfGmxbjDv[kBucXSxY3jvcoRzcWGuIH3lcYJz[W6nIIDveIVvfGmjbDDh[pRmeiB{IHjyd{BjgSC3c3nu[{BLSzFic4ThbY5qdmdiYomg[ox2d3Knc3PlcoNmKGOnbHytZoF{\WRiYYPzZZktKEWGNUCgQUAxNjByMk[g{txONg>?	M4\lT\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzOUezNVAyLz5{MUm3N\|ExOTxxYU6=
LoVo cells	NFrSb3hCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBie3OjeR?=		NXfiZYpmPDhidH:gO\|IhcA>?	M3r4fmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTH;Wc{Bk\WyuczDh[pRmeiB2ODD0c{A4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOC5yMEGg{txONg>?	NX7qTGtERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKxPFI6OjlpPkKyNVgzQTJ7PD;hQi=>
ST486 cells	NGjiRmxCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBie3OjeR?=		NGrUbmk1QCC2bzC3NkBp	MlXxRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCVVES4OkBk\WyuczDh[pRmeiB2ODD0c{A4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOC5yMEeg{txONg>?	Mo\OQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJzOEK5NlkoRjJ{MUiyPVI6RC:jPh?=
DLD1 cells	NYPwS4R5SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[XO\|YYm=		NHPlbnY1QCC2bzC3NkBp	NEXDTlhCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFTMSFEh[2WubIOgZYZ1\XJiNEigeI8hPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDBwMEC5JO69VS5?	MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjF6MkmyPUc,OjJzOEK5Nlk9N2F-
B16F10 cells	M4DRPWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIF{e2G7		MmHTOFghcA>?	MX\BcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IH3veZNmKEJzNl[xNEBk\WyuczDh[pRmeiB2ODDodpMh[nliTWTUJIF{e2G7LDDJR\|UxKD1iMj64NkDPxE1w	NG[2eWo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkWwN\|M3PCd-MkK1NFM{PjR:L3G+
MCF7 cells	NF7I[ZdCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBie3OjeR?=		MYC0PEBp	NYLCc25XSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNR2Y4KGOnbHzzJIFnfGW{IES4JIhzeyCkeTDNWHQh[XO\|YYmsJGlEPTBiPTCzMlA4KM7:TT6=	MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjVyM{O2OEc,OjJ3MEOzOlQ9N2F-
A431 cells	MVLDfZRwfG:6aXPpeJkh[XO\|YYm=		M4jUOVI1KGh?	MmXPR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVQ{OSClZXzsd{Bi\nSncjCyOEBpenNidYPpcochSW6wZYjpckBX\U[LVFOvdJJweGmmaYXtJIlw\GmmZTDzeIFqdmmwZzDifUBOXFRiYYPzZZktKEmFNUCgQUAxNjB5IN88UU4>	NEfBZWg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkW0NVA2OSd-MkK1OFExPTF:L3G+
MCF7 cells	NFvmUJNEgXSxdH;4bYNqfHliYYPzZZk>		NFHlToEzPCCq	MV3DfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDNR2Y4KGOnbHzzJIFnfGW{IEK0JIhzeyC3c3nu[{BCdm6neHnuJHZmTkmWQz;wdo9xcWSrdX2gbY9lcWSnIIP0ZYlvcW6pIHL5JG1VXCCjc4PhfUwhUUN3MDC9JFAvOThizszNMi=>	NY\ve21ERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK1OFExPTFpPkKyOVQyODVzPD;hQi=>
BJ cells	NVuzNoZ{S3m2b4TvfIlkcXS7IHHzd4F6		M17tdlczKGh?	M3fEZmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGJLKGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDDZYxk\WmwIFHNJIF{e2G7LDDJR\|UxKD1iMD6wNFIh\|ryPLh?=	MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjl{MUC4NUc,OjJ7MkGwPFE9N2F-
CEM cells	M{XxT2N6fG:2b4jpZ4l1gSCjc4PhfS=>		MonvO\|IhcA>?	M3LKS2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGNGVSClZXzsd{Bi\nSncjC3NkBpenNiYomgR4Ft[2WrbjDBUUBie3OjeTygTWM2OCB;IECuNFI{KM7:TT6=	M2XG[\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OUKxNFgyLz5{MkmyNVA5OTxxYU6=
MCF7 cells	NXrQeZp1S3m2b4TvfIlkcXS7IHHzd4F6		NV3EbGUzPzJiaB?=	NVPt[GE2S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVUOINzDj[YxteyCjZoTldkA4OiCqcoOgZpkhS2GuY3XpckBCVSCjc4PhfUwhUUN3MDC9JFAvODZ2IN88UU4>	MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjl{MUC4NUc,OjJ7MkGwPFE9N2F-
HeLa cells	NUDTSG9LS3m2b4TvfIlkcXS7IHHzd4F6		M{HxcVczKGh?	M3vMRWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhmVGFiY3XscJMh[W[2ZYKgO\|IhcHK\|IHL5JGNidGOnaX6gRW0h[XO\|YYmsJGlEPTBiPTCwMlE4PSEQvF2u	NYLPcoFYRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK5NlExQDFpPkKyPVIyODhzPD;hQi=>
HepG2 cells	NIDt[WhHfW6ldHnvckBie3OjeR?=		MX2yOEBp	MkLETY5pcWKrdHnvckBw\iC2ZXzvcYVz[XOnIHnuJIh2dWGwIFjldGczKGOnbHzzJIFnfGW{IEK0JIhzeyCkeTDUVmFRNVCFUj3FUGlUSSCjc4PhfUwhUUN3MDC9JFQvOTRizszNMi=>	NHXQV2I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{CxPFA6Pid-MkOwNVgxQTZ:L3G+
SW1116 cells	MXzBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDhd5NigQ>?		NVn6OJNPPDhiaB?=	MULBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFOZMUGxOkBk\WyuczDh[pRmeiB2ODDodpMh[nliTWTUJI1mfGixZDygTWM2OCB;IESuPVUh\|ryPLh?=	NV60clVuRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOwNVgxQTZpPkKzNFE5ODl4PD;hQi=>
HepG2 cells	M2jHUmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIF{e2G7		MVe0PEBp	MUHBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEincFeyJINmdGy\|IHHmeIVzKDR6IHjyd{BjgSCPVGSgcYV1cG:mLDDJR\|UxKD1iNj63N{DPxE1w	MnLrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyMUiwPVYoRjJ\|MEG4NFk3RC:jPh?=
BGC823 cells	MoWwRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZZN{[Xl?		Mn7mOFghcA>?	NWTvUYRnSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDCS2M5OjNiY3XscJMh[W[2ZYKgOFghcHK\|IHL5JG1VXCCvZYToc4QtKEmFNUCgQUA3Njh\|IN88UU4>	MonDQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyMUiwPVYoRjJ\|MEG4NFk3RC:jPh?=
HeLa cells	NYW4WIFHSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[XO\|YYm=		NIrwPHo1QCCq	NXe3dnNlSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDI[WxiKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDNWHQhdWW2aH;kMEBKSzVyIE2gPU4yOiEQvF2u	Mk[zQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyMUiwPVYoRjJ\|MEG4NFk3RC:jPh?=
HCT116 cells	MX7GeY5kfGmxbjDhd5NigQ>?			MmHjTY5pcWKrdHnvckBw\iCWTlnLMY1m\GmjdHXkJHRETjRxYnX0ZU1k[XOnaX6geJJidnOlcnnweIlwdiCrbjDoeY1idiCKQ2SxNVYh[2WubIOgZpkh[mW2YT3sZYN1[W2jc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhUUN3MDC9JFAvODN7IN88UU4>	MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzJ\|MkC2NEc,OjN{M{KwOlA9N2F-
HepG2 cells	M17nS2Z2dmO2aX;uJIF{e2G7		MmPOOFghcA>?	MULJcohq[mm2aX;uJI9nKHSnbH;t[ZJie2ViaX6gbJVu[W5iSHXwS\|Ih[2WubIOgZYZ1\XJiNEigbJJ{KGK7IGTSRXAuWEOULVXMTXNCNCCLQ{WwJF0hQC5\|IN88UU4>	MlvZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN{N{m4OlQoRjJ\|Mke5PFY1RC:jPh?=
SW1116 cells	MkfHSpVv[3Srb36gZZN{[Xl?		NF\FWmEzPCCq	Mm\1TY5pcWKrdHnvckBw\iC2ZXzvcYVz[XOnIHnuJIh2dWGwIGPXNVEyPiClZXzsd{Bi\nSncjCyOEBpenNiYomgWHJCWC2SQ2KtSWxKW0FiYYPzZZktKEmFNUCgQUA1NjF6IN88UU4>	M3XhUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2Mki2O\|YyLz5{NEK4Olc3OTxxYU6=
KE-97 cells	NWLjSlQ6S3m2b4TvfIlkcXS7IHHzd4F6		NX;qV3I{PzJiaB?=	MUPDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDLSU06PyClZXzsd{Bi\nSncjC3NkBpenNiYomgR4VtdFSrdILlMWdtdyCudX3pcoV{[2WwdDDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3MDC9JFAvOTNizszNMi=>	M3vz[\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2M{K4Nlg{Lz5{NEOyPFI5OzxxYU6=
Jurkat cells	M2P4XmN6fG:2b4jpZ4l1gSCjc4PhfS=>		M3zBSlczKGh?	NGfiR2tEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBLfXKtYYSgZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KEOnbHzUbZRz\S2JbH:gcJVucW6nc3PlcpQh[2WubDD2bYFjcWyrdImgZZN{[XluIFnDOVAhRSByLkG0JO69VS5?	NX;RVGU2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSzNlgzQDNpPkK0N\|I5Ojh\|PD;hQi=>
HuH7 cells	MVPDfZRwfG:6aXPpeJkh[XO\|YYm=		NUXDdmZ[PzJiaB?=	M1jiV2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGh2UDdiY3XscJMh[W[2ZYKgO\|IhcHK\|IHL5JGNmdGyWaYTy[U1IdG9ibIXtbY5me2OnboSgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUCgQUAxNjJ\|IN88UU4>	NW\1fHN7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSzNlgzQDNpPkK0N\|I5Ojh\|PD;hQi=>
BGC823 cells	MVXDfZRwfG:6aXPpeJkh[XO\|YYm=		MVK3NkBp	MUDDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDCS2M5OjNiY3XscJMh[W[2ZYKgO\|IhcHK\|IHL5JGNmdGyWaYTy[U1IdG9ibIXtbY5me2OnboSgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUCgQUAxNjN6IN88UU4>	MnLkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR\|MkiyPFMoRjJ2M{K4Nlg{RC:jPh?=
MCF7 cells	M2DGR2N6fG:2b4jpZ4l1gSCjc4PhfS=>		NW\oe\|N6PzJiaB?=	NYXIT4JtS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVUOINzDj[YxteyCjZoTldkA4OiCqcoOgZpkhS2WubGTpeJJmNUeubzDseY1qdmW\|Y3XueEBk\WyuII\pZYJqdGm2eTDhd5NigSxiSVO1NEA:KDBwNUKg{txONg>?	NUfidWhZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSzNlgzQDNpPkK0N\|I5Ojh\|PD;hQi=>
NIH/3T3 cells	MUnDfZRwfG:6aXPpeJkh[XO\|YYm=		M{f4Zlk3KGh?	MmSwR5l1d3SxeHnjbZR6KGGpYXnud5QhdW:3c3WgUmlJNzOWMzDj[YxteyCjZoTldkA6PiCqcoOgZpkhW1KEIHHzd4F6NCCLQ{WwJF0hOC5{IN88UU4>	NYnEcJFyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSzOlE2OjFpPkK0N\|YyPTJzPD;hQi=>
A2780 cells	MlXLR5l1d3SxeHnjbZR6KGG\|c3H5		MX65OkBp	MkSyR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVI4QDBiY3XscJMh[W[2ZYKgPVYhcHK\|IHL5JHNTSiCjc4PhfUwhUUN3MDC9JFAvOiEQvF2u	NWXGcI9IRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSzOlE2OjFpPkK0N\|YyPTJzPD;hQi=>
HT-29 cells	NITXeoNEgXSxdH;4bYNqfHliYYPzZZk>		NH;vSno6PiCq	M3nUemN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhVNTJ7IHPlcIx{KGGodHXyJFk3KGi{czDifUBUWkJiYYPzZZktKEmFNUCgQUAxNjJizszNMi=>	MmX6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR\|NkG1NlEoRjJ2M{[xOVIyRC:jPh?=
8505C cells	NILxXodEgXSxdH;4bYNqfHliYYPzZZk>		M4XGO\|k3KGh?	NWDiNXZ2S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hQDVyNVOgZ4VtdHNiYX\0[ZIhQTZiaILzJIJ6KFOUQjDhd5NigSxiSVO1NEA:KDBwMjFOwG0v	NIn4fIk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEO2NVUzOSd-MkSzOlE2OjF:L3G+
518A2 cells	NWPpXW1QS3m2b4TvfIlkcXS7IHHzd4F6		NYLGfGVNQTZiaB?=	MmrLR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gOVE5STJiY3XscJMh[W[2ZYKgPVYhcHK\|IHL5JHNTSiCjc4PhfUwhUUN3MDC9JFAvOiEQvF2u	NWLjUpJiRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSzOlE2OjFpPkK0N\|YyPTJzPD;hQi=>
MCF7 cells	Mni4R5l1d3SxeHnjbZR6KGG\|c3H5		MVS5OkBp	MVzDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDNR2Y4KGOnbHzzJIFnfGW{IEm2JIhzeyCkeTDTVmIh[XO\|YYmsJGlEPTBiPTCwMlQh\|ryPLh?=	MmfIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR\|NkG1NlEoRjJ2M{[xOVIyRC:jPh?=
A549 cells	NInmNZJEgXSxdH;4bYNqfHliYYPzZZk>		NGTFRY06PiCq	MYPDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDBOVQ6KGOnbHzzJIFnfGW{IEm2JIhzeyCkeTDTVmIh[XO\|YYmsJGlEPTBiPTCwMlYh\|ryPLh?=	MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDN4MUWyNUc,OjR\|NkG1NlE9N2F-
V79 MZ cells	M1PFXmZ2dmO2aX;uJIF{e2G7			MlrCTY5pcWKrdHnvckBw\iCqdX3hckBidGSxc4Tldo9v\SC\|eX70bIF{\SCneIDy[ZN{\WRiaX6gWlc6KE2cIHPlcIx{KGG\|c3Xzd4VlKGG\|IHnubIljcXSrb36gc4Yh[Wymb4P0[ZJwdmVic4nueIhme2m\|LDDJR\|UxKD1iMD6wNVEh\|ryPLh?=	NH20U4g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NESyNlUyQSd-MkS0NlI2OTl:L3G+
HEK293 cells	Mo\aR5l1d3SxeHnjbZR6KGG\|c3H5		MV63NkBp	NE\pV4VEgXSxdH;4bYNqfHliYXfhbY5{fCCKRVuyPVMh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IFPlcIxVcXSnclfsc{Bie3OjeTygTWM2OCB;IECuNFU3KM7:TT6=	Mnm5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5NkOyOlIoRjJ2N{[zNlYzRC:jPh?=
HeLa cells	MVfBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDhd5NigQ>?		NXLGT295OjRidH:gOFghcA>?	MX\BcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEinTHGgZ4VtdHNiYX\0[ZIhOjRidH:gOFghcHK\|IHL5JGNEUy16IHHzd4F6NCCLQ{WwJF0hOi55MjFOwG0v	NWHJdVFNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3PVI5OTFpPkK0O\|kzQDFzPD;hQi=>
A549 cells	NXfxbld3SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[XO\|YYm=		M1TNSFI1KHSxIES4JIg>	MUnBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEF3NEmgZ4VtdHNiYX\0[ZIhOjRidH:gOFghcHK\|IHL5JGNEUy16IHHzd4F6NCCLQ{WwJF0hOy5yNTFOwG0v	MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDd7MkixNUc,OjR5OUK4NVE9N2F-
HepG2 cells	MlXUR5l1d3SxeHnjbZR6KGG\|c3H5			MUnDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDI[ZBIOiClZXzsd{whTUN3MDC9JFIh\|ryPLh?=	M{TOTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3M{G2N\|E4Lz5{NUOxOlMyPzxxYU6=
Raji cells	NVrTT2RoS3m2b4TvfIlkcXS7IHHzd4F6			M3\IXWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHJicmliY3XscJMtKEWFNUCgQUAzKM7:TT6=	MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTNzNkOxO{c,OjV\|MU[zNVc9N2F-
BJ cells	MnTVR5l1d3SxeHnjbZR6KGG\|c3H5			NHnIW3NEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBDUiClZXzsd{whTUN3MDC9JFIh\|ryPLh?=	MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTNzNkOxO{c,OjV\|MU[zNVc9N2F-
HEK293 cells	M2TKb2N6fG:2b4jpZ4l1gSCjc4PhfS=>			NVW5RmdPS3m2b4TvfIlkcXS7IHHnZYlve3RiSFXLNlk{KGOnbHzzMEBGSzVyIE2gNkDPxE1w	NWLKWWY1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWzNVY{OTdpPkK1N\|E3OzF5PD;hQi=>
A549 cells	NGPoUJNEgXSxdH;4bYNqfHliYYPzZZk>		M1[4dlQ5KGh?	NF;v[5BEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBCPTR7IHPlcIx{KGGodHXyJFQ5KGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAxNjB{IN88UU4>	MmHnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6MkW5N\|QoRjJ3OEK1PVM1RC:jPh?=
HeLa cells	MYXDfZRwfG:6aXPpeJkh[XO\|YYm=		NHvZcpU1QCCq	MUXDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDI[WxiKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDNWHQh[XO\|YYmsJGlEPTBiPTCwMlAzPSEQvF2u	MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh{NUmzOEc,OjV6MkW5N\|Q9N2F-
PC3 cells	Ml7ZR5l1d3SxeHnjbZR6KGG\|c3H5		NITqb4k1QCCq	NXHEN5VES3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hWEN\|IHPlcIx{KGGodHXyJFQ5KGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAxNjB\|MTFOwG0v	NGj4e249[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUiyOVk{PCd-MkW4NlU6OzR:L3G+
MGC-803 cells	M4\wZ2Z2dmO2aX;uJIF{e2G7		NV3YOphEOjRiaB?=	NUHqdZFOUW6qaXLpeIlwdiCxZjD0[YxwdWW{YYPlJIlvKGi3bXHuJG1ISy16MEOgZ4VtdHNiYX\0[ZIhOjRiaILzJIJ6KFSUQWCtVGNTNUWOSWPBJIF{e2G7LDDJR\|UxKD1iOD65O{DPxE1w	M1POc\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4OUCwOlU3Lz5{NkmwNFY2PjxxYU6=
Sf9 insect cells	MmnZSpVv[3Srb36gZZN{[Xl?		NGX3cWIyOCCvaX7z	NFjHUnpKdmirYnn0bY9vKG:oIF6teIVzdWmwYXygS3NVKHSjZ3fl[EBz\WOxbXLpcoFvfCCodXzsMYxmdme2aDDoeY1idiCFSFuxJIV5eHKnc4Pl[EBqdiCkYXP1cI93cXK3czDT[lkhcW6\|ZXP0JINmdGy\|IHHmeIVzKDFyIH3pcpMh[nlibIXtbY5me2OnboSgRWRRNUeubzDhd5NigSxiSVO1NEA:KDBwMECxNkDPxE1w	M3LyWFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5MEi5NlEyLz5{N{C4PVIyOTxxYU6=
Sf21 cells	MVHGeY5kfGmxbjDhd5NigQ>?		MUm2NEBucW6\|	MV7Jcohq[mm2aX;uJI9nKGi3bXHuJJJm[2:vYnnuZY51KEqDS{Kg[ZhxemW\|c3XkJIlvKFOoMkGgZ4VtdHNiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJIlvKFWuaXfoeE1ESUeDR1HJSXRFU0W\WWTWT2QheGixc4Doc5J6dGG2aX;uJJBz\S2rbnP1ZoF1\WRiYnXmc5JmKHO3YoP0doF1\SCjZHTpeIlwdiCjbnSgcYVie3W{ZXSgZYZ1\XJiNkCgcYlveyCkeTDMRW5ETSCmZYTlZ5Rqd25ibXX0bI9lNCCLQ{WwJF0hOC5yMEKg{txONg>?	MkTsQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjdzM{ezOVkoRjJ5MUO3N\|U6RC:jPh?=
Neuro2a cells	NGW1OVREgXSxdH;4bYNqfHliYYPzZZk>		NYPZc2s4PzJiaB?=	MkGxR5l1d3SxeHnjbZR6KGGpYXnud5QhdW:3c3WgUoV2em9{YTDj[YxteyCjc4Pld5Nm\CCjczDj[YxtKH[rYXLpcIl1gSCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOC5yMUGzJO69VS5?	NEjISGg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEG1NlQzPyd-MkixOVI1Ojd:L3G+
MDA-MB-231 cells	MnzxSpVv[3Srb36gZZN{[Xl?		NIj1WVUyPiCq	NYfac2dwUW6qaXLpeIlwdiCxZjDy[ZRqdm:kbHHzeI9u[SCycn;0[YlvKHCqb4PwbI9zgWyjdHnvckBqdiCqdX3hckBOTEFvTVKtNlMyKGOnbHzzJIFnfGW{IEG2JIhzeyCkeTDIc4VkcHO2IEOzN\|QzKHO2YXnubY5oKGKjc3XkJIZtfW:{ZYPj[Y5k\SCjc4PhfUwhUUN3MDC9JFAvODZ4IN88UU4>	M1XOWVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6NEOxN\|QzLz5{OESzNVM1OjxxYU6=
Sf9 insect cells	MVrGeY5kfGmxbjDhd5NigQ>?		MUWyNEBucW6\|	NUP0ZVFNUW6qaXLpeIlwdiCxZjDy[YNwdWKrbnHueEBpfW2jbjDOMZRmem2rbnHscJkhT1OWLYTh[4dm\CCHR1\SJGw5PTiUL2S3PVBON0N5OUfTJJRzcXCuZTDteZRidnRiZYjwdoV{e2WmIHnuJIJi[3Wub4\pdpV{KGmwIGPmPUBqdnOnY4SgZ4VtdHNicILlbY5kfWKjdHXkJIZweiB{MDDtbY5{KG[xbHzve4VlKGK7IHHk[Il1cW:wIH;mJHs{O1CfLVHUVEBu\WG\|dYLl[EBi\nSncjCyJIhzeyCkeTDmbYx1\XJvYnnu[Ilv\yCvZYToc4QtKEmFNUCgQUAxNjByMEK5JO69VS5?	NGHVSoM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OES4NlE2OSd-Mki0PFIyPTF:L3G+
HEK293 cells	MXXDfZRwfG:6aXPpeJkh[XO\|YYm=		M1jLOlczKGh?	MkPvR5l1d3SxeHnjbZR6KGGpYXnud5QhUEWNMkmzJINmdGy\|IHHzd4V{e2WmIHHzJIRm[3KnYYPlJIlvKGOnbHygeoli[mmuaYT5JIFnfGW{IEeyJIhzeyCkeTDD[YxtXGm2ZYKgS4xwKGy3bXnu[ZNk\W62IHHzd4F6NCCFQ{WwJF0hOC5yMEO1OEDPxE1w	NH76Vlc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OE[yOFcxOSd-Mki2NlQ4ODF:L3G+
BT549 cells	MkTuR5l1d3SxeHnjbZR6KGG\|c3H5		MWeyOEBp	Mmr0R5l1d3SxeHnjJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQmS1OFkh[2WubIOgbY5kfWKjdHXkJIZweiB{NDDodpMh[nliTWTUJIF{e2G7LDDJR\|UxKD1iMD6wPEDPxE1w	NYnRUZV1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki3NFU1OzJpPkK4O\|A2PDN{PD;hQi=>
MDA-MB-468 cells	NYHwXYdbS3m2b4TvfIlkcXS7IHHzd4F6		MYeyOEBp	NFTl[lJEgXSxdH;4bYMh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNSGEuVUJvNE[4JINmdGy\|IHnuZ5Vj[XSnZDDmc5IhOjRiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDBwMUWg{txONg>?	MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDdyNUSzNkc,Ojh5MEW0N\|I9N2F-
MDA-MB-231 cells	NX3WcmdZS3m2b4TvfIlkcXS7IHHzd4F6		MXyyOEBp	MX;DfZRwfG:6aXOgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCPRFGtUWIuOjNzIHPlcIx{KGmwY4XiZZRm\CCob4KgNlQhcHK\|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFAvOjRizszNMi=>	M1fMblxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6N{C1OFMzLz5{OEewOVQ{OjxxYU6=
Vero cells	MXXDfZRwfG:6aXPpeJkh[XO\|YYm=		MUOyJIRigXN?	MVvDfZRwfG:6aXPpeJkh[WejaX7zeEBC\nKrY3HuJIdz\WWwIH3vcotmgSCYZYLvJINmdGy\|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiClZXzsJJZq[WKrbHn0fUBi\nSncjCyJIRigXNiYomgZ4VtdC22aYTldk1odG9ibIXtbY5me2OnboSgZZN{[XluIGTDOVAhRSByLkCwNlQh\|ryPLh?=	NVe4RpU3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki3OlM3PDVpPkK4O\|Y{PjR3PD;hQi=>
L929 cells	NGXzPHNCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBie3OjeR?=		MVi1JIRigXN?	MYrBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IH3veZNmKEx7MkmgZ4VtdHNiYX\0[ZIhPSCmYYnzJIJ6KFeVVD2xJIF{e2G7LDDJR\|UxKD1iMD6yJO69VS5?	MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDl3NkmxOUc,Ojh7NU[5NVU9N2F-
KB-3-1 cells	NEXoSFNCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBie3OjeR?=		NHPxS\|Y2KGSjeYO=	Ml7uRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCNQj2zMVEh[2WubIOgZYZ1\XJiNTDkZZl{KGK7IGfTWE0yKGG\|c3H5MEBKSzVyIE2gNE4zKM7:TT6=	NFi1Snc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEm1OlkyPSd-Mki5OVY6OTV:L3G+
MCF7 cells	Mn;0RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZZN{[Xl?		M{jKOVUh\GG7cx?=	M3\VSWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTVPGO{Bk\WyuczDh[pRmeiB3IHThfZMh[nliV2PUMVEh[XO\|YYmsJGlEPTBiPTCxMlgh\|ryPLh?=	NHnGcZY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEm1OlkyPSd-Mki5OVY6OTV:L3G+
FS4-LTM cells	MUHBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDhd5NigQ>?		MXOyOEBp	NGLxRWhCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF\TOE1NXE1iY3XscJMh[W[2ZYKgNlQhcHK\|IHL5JHdUXC1zIHHzd4F6NCCLQ{WwJF0hOi56IN88UU4>	M3HvfFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6OUW2PVE2Lz5{OEm1OlkyPTxxYU6=
Vero cells	NXqwXIdCS3m2b4TvfIlkcXS7IHHzd4F6		MYCyJIRigXN?	MnHyR5l1d3SxeHnjbZR6KGGpYXnud5QhSW[{aXPhckBoemWnbjDtc45s\XliVnXyc{Bk\WyuczDh[pRmeiB{IHThfZMh[nliQ3XscHRqfGW{LVfsc{BtfW2rbnXzZ4VvfCClZXzsJJZq[WKrbHn0fUBie3OjeTygTWM2OCB;IECuNFAzPCEQvF2u	NH62NlA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEm5N\|ExPid-Mki5PVMyODZ:L3G+
HepG2 cells	MWrDfZRwfG:6aXPpeJkh[XO\|YYm=	NHrrcWcyODBidV2=	M2TmcFMh\GG7cx?=	M3Xme2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhmeEd{IHPlcIx{KGG2IEGwNEB2VSCjZoTldkA{KGSjeYOgZpkhS2WubGTpeIVzNUeubzDseY1qdmW\|Y3XueEBk\WyuII\pZYJqdGm2eTDhd5NigSxiSVO1NEA:KDBwMEG4JO69VS5?	NEDhZYw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEm5N\|ExPid-Mki5PVMyODZ:L3G+
NIH/3T3 cells	NYHBRYF3S3m2b4TvfIlkcXS7IHHzd4F6		NYOyb4VPQTZiaB?=	MU\DfZRwfG:6aXPpeJkh[WejaX7zeEBud3W\|ZTDOTWgwO1R\|IHPlcIx{KGGodHXyJFk3KGi{czDifUBUWkJiYYPzZZktKEWFNUCgQUAxNjByODFOwG0v	NYSweppzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkmxPVc4OzBpPkK5NVk4PzNyPD;hQi=>
518A2 cells	NGG3UFhEgXSxdH;4bYNqfHliYYPzZZk>		NFe2Ulg6PiCq	MlXVR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gOVE5STJiY3XscJMh[W[2ZYKgPVYhcHK\|IHL5JHNTSiCjc4PhfUwhTUN3MDC9JFAvODNizszNMi=>	M1W0NFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7MUm3O\|MxLz5{OUG5O\|c{ODxxYU6=
A549 cells	MXjDfZRwfG:6aXPpeJkh[XO\|YYm=		MUS5OkBp	MnznR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVU1QSClZXzsd{Bi\nSncjC5OkBpenNiYomgV3JDKGG\|c3H5MEBGSzVyIE2gNE4xPCEQvF2u	M4DoWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7MUm3O\|MxLz5{OUG5O\|c{ODxxYU6=
MCF7 cells	NETp[ZZEgXSxdH;4bYNqfHliYYPzZZk>		M1zr[Fk3KGh?	M2nJZ2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJG1ETjdiY3XscJMh[W[2ZYKgPVYhcHK\|IHL5JHNTSiCjc4PhfUwhTUN3MDC9JFAvOSEQvF2u	M37zOVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7MUm3O\|MxLz5{OUG5O\|c{ODxxYU6=
A2780 cells	M1TpdGN6fG:2b4jpZ4l1gSCjc4PhfS=>		NWnoSpR7QTZiaB?=	NV\DfFRCS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hSTJ5OECgZ4VtdHNiYX\0[ZIhQTZiaILzJIJ6KFOUQjDhd5NigSxiRVO1NEA:KDBwMUKg{txONg>?	Mm\5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjlzOUe3N\|AoRjJ7MUm3O\|MxRC:jPh?=
HT-29 cells	M1nUOmN6fG:2b4jpZ4l1gSCjc4PhfS=>		NFX0NlA6PiCq	MknSR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gTHQuOjliY3XscJMh[W[2ZYKgPVYhcHK\|IHL5JHNTSiCjc4PhfUwhTUN3MDC9JFAvOTVizszNMi=>	MnLXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjlzOUe3N\|AoRjJ7MUm3O\|MxRC:jPh?=
PC3 cells	MWPDfZRwfG:6aXPpeJkh[XO\|YYm=			M1LIfGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHBEOyClZXzsd{BjgSC\|dXzmc5Jpd2SjbXnu[UBDKGG\|c3H5MEBKSzVyIE2gNE4xOTdizszNMi=>	NYHkbmxKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkmzPFkyOjJpPkK5N\|g6OTJ{PD;hQi=>
HCT116 cells	NXWxV\|ROS3m2b4TvfIlkcXS7IHHzd4F6			M1;ZfmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhEXDFzNjDj[YxteyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCLQ{WwJF0hOC5yNUWg{txONg>?	MXm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTN6OUGyNkc,Ojl\|OEmxNlI9N2F-
insect cells	NUn5bZNGTnWwY4Tpc44h[XO\|YYm=		M33KPVMxKG2rboO=	NWPVZphuUW6qaXLpeIlwdiCxZjDy[YNwdWKrbnHueEBpfW2jbjDQSGdHWmKndHGg[ZhxemW\|c3XkJIlvKGmwc3XjeEBk\WyuczD1d4lv\yCXbHnnbJQuWG:ueTDHRXRcTUG\KEG6NVoyMV2wIHHzJJN2[nO2cnH0[UBi\nSncjCzNEBucW6\|IHL5JGxCVkOHIH3leIhw\CxiSVO1NEA:KDBwMECwO\|Yh\|ryPLh?=	MXq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTV2OUizOkc,Ojl3NEm4N\|Y9N2F-
Sf9 insect cells	MUPGeY5kfGmxbjDhd5NigQ>?		M{fY[lYxKG2rboO=	NEDy[5dKdmirYnn0bY9vKG:oIILlZ49u[mmwYX70JIh2dWGwIFvEVkBmgHC{ZYPz[YQhcW5iU3[5JIlve2WldDDj[YxteyC3c3nu[{BWdGmpaIStR2FISUeDSVXUSGtGYVmWVlvEJIF{KHO3YoP0doF1\SCjZoTldkA3OCCvaX7zJIJ6KEyDTlPFJI1mfGixZDygTWM2OCB;IECuNFAzOSEQvF2u	NHvmS4M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUW0PVg{Pid-Mkm1OFk5OzZ:L3G+
insect cells	M4jiOGZ2dmO2aX;uJIF{e2G7		NWrsUWxqOTBibXnudy=>	M2Th[WlvcGmkaYTpc44hd2ZicnXjc41jcW6jboSgbJVu[W5iU4LjJIV5eHKnc4Pl[EBqdiCrboPlZ5Qh[2WubIOgeZNqdmdiVXzp[4h1NVCxbImgS2FVY0WDWTixPlE7OSmfbjDhd{B{fWK\|dILheIUh[W[2ZYKgNVAhdWmwczDifUBNSU6FRTDt[ZRpd2RuIFnDOVAhRSByLkCwOUDPxE1w	NILCXWI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUW0PVg{Pid-Mkm1OFk5OzZ:L3G+
insect cells	MnL0SpVv[3Srb36gZZN{[Xl?		M4Ppb\|E2KG2rboO=	NYnhVFZDUW6qaXLpeIlwdiCxZjDy[YNwdWKrbnHueEBpfW2jbjDDSGsyN0O7Y3zpckBDKGW6cILld5Nm\CCrbjDpcpNm[3RiY3XscJMhfXOrbnegWYxq\2i2LVPGSmtPUV[WUGLUVHBRW1GJSz3hcYll\SCjczDzeYJ{fHKjdHWgZYZ1\XJiMUWgcYlveyCkeTDMRW5ETSCvZYToc4QtKEmFNUCgQUAxNjB{NTFOwG0v	Mo\UQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl3NEm4N\|YoRjJ7NUS5PFM3RC:jPh?=
insect cells	MnHISpVv[3Srb36gZZN{[Xl?		NHvoOHEyPSCvaX7z	NH3ubYVKdmirYnn0bY9vKG:oIILlZ49u[mmwYX70JIh2dWGwIFPET\|EwS3mlbHnuJGIh\XiycnXzd4VlKGmwIHnud4VkfCClZXzsd{B2e2mwZzDVcIlocHRvQ1\GT25KXlSSUmTQVHBUWUeNLXHtbYRmKGG\|IIP1ZpN1emG2ZTDh[pRmeiBzNTDtbY5{KGK7IFzBUmNGKG2ndHjv[EwhUUN3MDC9JFAvODJ3IN88UU4>	M1GyR\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NUS5PFM3Lz5{OUW0PVg{PjxxYU6=
Sf9 insect cells	Mmn3SpVv[3Srb36gZZN{[Xl?		MnXZNVUhdWmwcx?=	NInUfmpKdmirYnn0bY9vKG:oIILlZ49u[mmwYX70JIh2dWGwIF\seFEh\XiycnXzd4VlKGmwIGPmPUBqdnOnY4SgZ4VtdHNidYPpcochXWyrZ3j0MXRMKHCncITp[IUh[XNic4Xid5Rz[XSnIHHmeIVzKDF3IH3pcpMh[nliTFHOR2UhdWW2aH;kMEBKSzVyIE2gNE4xOzVizszNMi=>	MnjqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl3NEm4N\|YoRjJ7NUS5PFM3RC:jPh?=
Sf21 insect cells	NIHScoNHfW6ldHnvckBie3OjeR?=		NWfDd2F3OTVibXnudy=>	MWrJcohq[mm2aX;uJI9nKHKnY3;tZolv[W62IHj1cYFvKEG3cn;yZU1CKGW6cILld5Nm\CCrbjDT[lIyKGmwc3XjeEBk\WyuczD1d4lv\yCXbHnnbJQuWlKUU1zMSUBieyC\|dXLzeJJifGViYX\0[ZIhOTVibXnud{BjgSCOQV7DSUBu\XSqb3SsJGlEPTBiPTCwMlA{QSEQvF2u	MoTSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl3NEm4N\|YoRjJ7NUS5PFM3RC:jPh?=
insect cells	M{npW2Z2dmO2aX;uJIF{e2G7		NXnNfnRDPjBibXnudy=>	MnX0TY5pcWKrdHnvckBw\iC{ZXPvcYJqdmGwdDDoeY1idiCDS2SxJIV5eHKnc4Pl[EBqdiCrboPlZ5Qh[2WubIOgeZNqdmdiQ2LFRpRq\GViYYOgd5Vje3S{YYTlJIFnfGW{IE[wJI1qdnNiYomgUGFPS0VibXX0bI9lNCCLQ{WwJF0hOC5yNU[g{txONg>?	MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTV2OUizOkc,Ojl3NEm4N\|Y9N2F-
Sf9 insect cells	M1LBdGZ2dmO2aX;uJIF{e2G7		NX3MNWw1PjBibXnudy=>	NEK3cpVKdmirYnn0bY9vKG:oIILlZ49u[mmwYX70JIh2dWGwIF\BT{BmgHC{ZYPz[YQhcW5iU3[5JIlve2WldDDj[YxteyC3c3nu[{BWdGmpaIStWGsheGWydHnk[UBieyC\|dXLzeJJifGViYX\0[ZIhPjBibXnud{BjgSCOQV7DSUBu\XSqb3SsJGlEPTBiPTCwMlA3OiEQvF2u	MoXMQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl3NEm4N\|YoRjJ7NUS5PFM3RC:jPh?=
insect cells	NX3ReVBpTnWwY4Tpc44h[XO\|YYm=		MoL2OlAhdWmwcx?=	NXLYOHBSUW6qaXLpeIlwdiCxZjDy[YNwdWKrbnHueEBpfW2jbjDBRmwh\XiycnXzd4VlKGmwIHnud4VkfCClZXzsd{B2e2mwZzDVcIlocHRvVFugdIVxfGmmZTDhd{B{fWK\|dILheIUh[W[2ZYKgOlAhdWmwczDifUBNSU6FRTDt[ZRpd2RuIFnDOVAhRSByLkK5JO69VS5?	MmXZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl3NEm4N\|YoRjJ7NUS5PFM3RC:jPh?=
insect cells	M4T6SGZ2dmO2aX;uJIF{e2G7		NEPoVI83OCCvaX7z	M2fyZmlvcGmkaYTpc44hd2ZicnXjc41jcW6jboSgbJVu[W5iYz3NSXQh\XiycnXzd4VlKGmwIHnud4VkfCClZXzsd{B2e2mwZzDVcIlocHRvQ1HHRWdCUUWWRFvFXXlVXkuGIHHzJJN2[nO2cnH0[UBi\nSncjC2NEBucW6\|IHL5JGxCVkOHIH3leIhw\CxiSVO1NEA:KDBwM{Gg{txONg>?	MojiQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl3NEm4N\|YoRjJ7NUS5PFM3RC:jPh?=
PC3 cells	NXjsS4x3S3m2b4TvfIlkcXS7IHHzd4F6		M3fRdVczKGh?	M1:2RmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHBEOyClZXzsd{Bi\nSncjC3NkBpenNiYomgV3JDKGG\|c3H5MEBKSzVyIE2gNE4xOzlizszNMi=>	NX7YOplbRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm1OVgyOTlpPkK5OVU5OTF7PD;hQi=>
Sf9 cells	MUPGeY5kfGmxbjDhd5NigQ>?		M2WyZlQ2KG2rboO=	NGrwZnpKdmirYnn0bY9vKG:oIILlZ49u[mmwYX70JIh2dWGwIFOteIVzdWmwYXygTIl{NXSjZ3fl[E9PNXSncn3pcoFtKEeVVD30ZYdo\WRiRVfGVkApPjZ6IITvJFEzOTBicnXzbYR2\XNrIHX4dJJme3OnZDDpckBj[WO3bH;2bZJ2eyCrbn\lZ5Rm\CCVZkmgZ4VtdHNidYPpcochWG:ueT2oS4x2NCCWeYKpJIF{KHO3YoP0doF1\SCvZXHzeZJm\CCjZoTldkA1PSCvaX71eIV{KGK7IFvpcoF{\S2JbH:gcJVucW6nc3PlcpQh[XO\|YYmsJGlEPTBiPTCwMlA1PyEQvF2u	NGL2UXk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUmwNlcyQSd-Mkm5NFI4OTl:L3G+
Sf9 cells	M3njbGZ2dmO2aX;uJIF{e2G7		MnjNOFUhdWmwcx?=	M{DPXmlvcGmkaYTpc44hd2ZicnXjc41jcW6jboSgbJVu[W5iTj30[ZJucW6jbDDHV3QufGGpZ3XkJGhGWjJiKE[3PUB1dyBzMkW1JJJme2mmdXXzLUBmgHC{ZYPz[YQhcW5iYnHjeYxwfmm{dYOgbY5n\WO2ZXSgV4Y6KGOnbHzzJJV{cW6pIGDvcJkuMEeudTygWJlzMSCjczDzeYJ{fHKjdHWgcYVie3W{ZXSgZYZ1\XJiNEWgcYlvfXSnczDifUBMcW6jc3WtS4xwKGy3bXnu[ZNk\W62IHHzd4F6NCCLQ{WwJF0hOC5yNkC4JO69VS5?	M4jBOVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7OUCyO\|E6Lz5{OUmwNlcyQTxxYU6=
HT-29 cells	NHnDcllHfW6ldHnvckBie3OjeR?=		MYGzJIg>	MVzJcohq[mm2aX;uJI9nKG2rdH;jbI9v\HKrYXygcYVu[nKjbnWgdI91\W62aXHsJIlvKGi3bXHuJGhVNTJ7IHPlcIx{KGGodHXyJFMhcHK\|IHL5JGpENTFic4ThbY5qdmdiYnHz[YQh\my3b4Lld4NmdmOnIHHzd4F6NCCLQ{WwJF0hOC5yMjFOwG0v	NIfXNFc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9\|MEC1O\|E2PSd-M{CwOVcyPTV:L3G+
Sf9 cells	NXSwbJp{TnWwY4Tpc44h[XO\|YYm=			MWXJcohq[mm2aX;uJI9nKE5vdHXycYlv[WxiRlzBS{11[WepZXSgbJVu[W5iZoXscE1t\W6pdHigR2RMOTJiKEGgeI8hOTR7MDDy[ZNq\HWnczmvUk11\XKvaX7hcEBJcXNvdHHn[4VlKEO7Y1ugLFEhfG9iNUiwJJJme2mmdXXzLUBmgHC{ZYPz[YQhcW5iU3[5JINmdGy\|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiCDVGCt[IVx\W6mZX70JHVNcWeqdD20SU1DWDFiKGTodlM4N1SqckS2LUB{fWK\|dILheIUheGWydHnk[UBxcG:\|cHjvdplt[XSrb36gdJItKEmFNUCgQUAxNjB3MzFOwG0v	NXzUb45qRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CwOlc{PThpPkOwNFY4OzV6PD;hQi=>
Sf9 cells	Mn7hSpVv[3Srb36gZZN{[Xl?			MVvJcohq[mm2aX;uJI9nKE5vdHXycYlv[WxiRlzBS{11[WepZXSgbJVu[W5iZoXscE1t\W6pdHigR2RMOTJiKEGgeI8hOTR7MDDy[ZNq\HWnczmvUk11\XKvaX7hcEBJcXNvdHHn[4VlKEO7Y1ugLFEhfG9iNUiwJJJme2mmdXXzLUBmgHC{ZYPz[YQhcW5iU3[5JINmdGy\|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiCDVGCt[IVx\W6mZX70JHVNcWeqdD20SU1DWDFiKGTodlM4N1SqckS2LUB{fWK\|dILheIUheGWydHnk[UBxcG:\|cHjvdplt[XSrb36gdJItKEmFNUCgQUAxNjB3MzFOwG0v	NXXQeJU5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CwOlc{PThpPkOwNFY4OzV6PD;hQi=>
Sf9 cells	NHKxfmJHfW6ldHnvckBie3OjeR?=			MkTQTY5pcWKrdHnvckBw\iCQLYTldo1qdmGuIF\MRWcufGGpZ3XkJIh2dWGwIH\1cIwudGWwZ4ToJGNFUzF\|IDixJJRwKDF3MUKgdoV{cWS3ZYOpM24ufGW{bXnuZYwhUGm\|LYTh[4dm\CCFeXPLJEgyKHSxIEW4NEBz\XOrZIXld{kh\XiycnXzd4VlKGmwIGPmPUBk\WyuczDhd5Nme3OnZDDhd{Bz\WS3Y4Tpc44hcW5iQWTQMYRmeGWwZHXueEBWVGmpaIStOGUuSlBzIDjUbJI{Py:WaIK0Okkhe3Wkc4TyZZRmKHCncITp[IUheGixc4Doc5J6dGG2aX;uJJBzNCCLQ{WwJF0hOC5yNUeg{txONg>?	NHzTUIs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9\|MEC2O\|M2QCd-M{CwOlc{PTh:L3G+
Sf9 cells	M2TNbmZ2dmO2aX;uJIF{e2G7			M2m5RWlvcGmkaYTpc44hd2ZiTj30[ZJucW6jbDDGUGFINXSjZ3fl[EBpfW2jbjDmeYxtNWynbnf0bEBETEtzMzCoNUB1dyBzNUGyJJJme2mmdXXzLU9PNXSncn3pcoFtKEircz30ZYdo\WRiQ4njT{ApOSC2bzC1PFAhemW\|aXT1[ZMqKGW6cILld5Nm\CCrbjDT[lkh[2WubIOgZZN{\XO\|ZXSgZZMhemWmdXP0bY9vKGmwIFHUVE1l\XCnbnTlcpQhXUyrZ3j0MVRGNUKSMTCoWIhzOzdxVHjyOFYqKHO3YoP0doF1\SCyZYD0bYRmKHCqb4PwbI9zgWyjdHnvckBxeixiSVO1NEA:KDBwMEW3JO69VS5?	M2W2O\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyME[3N\|U5Lz5\|MEC2O\|M2QDxxYU6=
HCT116 cells	MojQR5l1d3SxeHnjbZR6KGG\|c3H5		MlPGOFghcA>?	MoTHR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gTGNVOTF4IHPlcIx{KGG\|c3Xzd4VlKGG\|IHTlZ5Jm[XOnIHnuJINmdGxidnnhZoltcXS7IHHmeIVzKDR6IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSByLkCzJO69VS5?	M37iZ\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyMUC2NlkyLz5\|MEGwOlI6OTxxYU6=
Huh7.5 cells	NEnYOI5EgXSxdH;4bYNqfHliYYPzZZk>		MYC0PEBp	MXnDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDIeYg4NjViY3XscJMh[XO\|ZYPz[YQh[XNiZHXjdoVie2ViaX6gZ4VtdCC4aXHibYxqfHliYX\0[ZIhPDhiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDBwNjFOwG0v	NGPDZpU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9\|MEGwOlI6OSd-M{CxNFYzQTF:L3G+
K562 cells	NIX2XpdEgXSxdH;4bYNqfHliYYPzZZk>		Mmf4OFghcA>?	M1nrRWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGs2PjJiY3XscJMh[XO\|ZYPz[YQh[XNiZHXjdoVie2ViaX6gZ4VtdCC4aXHibYxqfHliYX\0[ZIhPDhiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDFwNzFOwG0v	NF63bpo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9\|MEGwOlI6OSd-M{CxNFYzQTF:L3G+
LO2 cells	MX;DfZRwfG:6aXPpeJkh[XO\|YYm=		NG\5c4I1QCCq	MX;DfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDMU\|Ih[2WubIOgZZN{\XO\|ZXSgZZMh\GWlcnXhd4UhcW5iY3XscEB3cWGkaXzpeJkh[W[2ZYKgOFghcHK\|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFkvPSEQvF2u	NHvSN3o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9\|MEGwOlI6OSd-M{CxNFYzQTF:L3G+

... Click to View More Cell Line Experimental Data

Assay

Methods	Test Index	PMID
Western blot	FAK / RIP; PubMed: 15121855 Mol Cell Biol Western blot (WB) analysis of BT-20 and BT-474 lysates treated with staurosporine (200 nM). Control cells were treated with dimethyl sulfoxide for 18 h. p-Akt / Akt / PARP /Cleaved PARP; PubMed: 24174874 Int J Nanomedicine Western blot analysis for Akt, P-Akt, and cleaved poly(ADP-ribose) polymerase. U87 cells were incubated with 200 nM, 10 nM, and 0.1 nM of staurosporine encapsulated in liposomes and staurosporine for 32 hours. Ambra1; PubMed: 24587252 PLoS One SW620 cells treated with various doses of staurosporine for 6 h. Ambra1 levels were measured by Western blot.	15121855 24174874 24587252
Growth inhibition assay	Cell viability; PubMed: 25215174 Oxid Med Cell Longev Staurosporine reduces cerebellar astrocytes viability. (a) Cerebellar astrocytes were treated with staurosporine 0.1 μM, 0.25 μM, and 0.5 μM for 24 h and the cell viability was measured by MTT transformation. (b) Cerebellar astrocytes were treated with staurosporine 0.5 μM for 6, 12, and 24 h and the cell viability was measured by MTT transformation. Data are presented as mean ± SEM of four independent experiments. ∗ is significantly different from control (P < 0.05).	25215174
Immunofluorescence	Phalloidin / Type II collagen; PubMed: 22684244 Exp Mol Med Cell were cultured in the absence (a-f) or presence of staurosporine (STSN, 5 × 10-9M) or cytochalasin D (CD, 1 µg/ml) for 1 (upper panel) or 2 (lower panel) days at low density and stained for F-actin (Phalloidin) and type II collagen (Type II). STSN: Staurosporine. Tubulin / Actin; PubMed: 25215174 Oxid Med Cell Longev Morphological changes of astrocytes induced by St are evidenced by the rearrangement of cytoskeletal proteins. Astrocytes were treated with St (0.5 μM) for 12 hours and then were labelled with rhodamine-phalloidin or immunostained for tubulin. Representative images of phase contrast, rhodamine-phalloidin, and tubulin are shown in control and St treated astrocytes. Scale bar represents 50 μm. FAK 4.47; PubMed: 15121855 Mol Cell Biol BT-20 or BT-474 cell culture were plated on six-well plates and were treated with staurosporine (200 nM) after 24 h. After 6 h of treatment, cells were immunostained with anti-FAK 4.47 antibody (white arrowheads mark some focal adhesions). cleaved-caspase 3; PubMed: 19840952 Cardiovasc Res Representative images (×1000 magnification) showing vehicle treated (C) and staurosporine treated (D) cells stained with anti-cleaved caspase 3 antibody and DAPI. Annexin; PubMed: 15140398 Neoplasia Induction of apoptosis with staurosporine resulting in activation of the ICE-NIRF probe. Gli36 cells were treated with 50 µM staurosporine for 24 hours (A-C) or with the same percentage of DMSO (0.01%) to which experimental wells were exposed (D-488nm laser, E-633nm laser and F-bright field). To examine the role of caspase-1 in staurosporine-induced apoptosis and probe activation, cells were coincubated in caspase-1 inhibitor (10 µM) and staurosporine (G-I). Staurosporine induces apoptosis, indicated by the positive annexin staining viewed with the 488-nm laser (A), which colocalized with activated probe viewed with the 633-nm laser (B). Coincubation of the caspase-1 inhibitor with staurosporine did not completely block apoptosis, indicated by the relatively higher number of apoptotic cells stained with annexin (G), as those that activated the probe (H). Magnification, x 40; scale bar, 50 µM. Pyk2; PubMed: 19880522 J Biol Chem Pyk2 translocates to the nucleus upon staurosporine addition to ID8 cells. Confocal immunofluorescent analysis of endogenous Pyk2 upon DMSO (control) or 1 μm staurosporine addition for 2 h. The scale bar is 10 μm.	22684244 25215174 15121855 19840952 15140398 19880522

体内研究

在局部贫血前，使用Staurosporine(0.1-10 ng)预处理局部贫血沙鼠和大鼠模型，可防止神经元损伤，这种作用存在剂量依赖性，说明CAl锥体细胞死亡涉及PKC。^[2]

激酶实验： ^[1]	- 合并 Enzyme assay and binding assay: Protein kinase C is assayed in a reaction mixture (0.25 mL) containing 5 μmol of Tris/HCl, pH 7.5, 2.5 μmol of magnesium acetate, 50 μg of histone II S, 20 μg of phosphatidylserine, 0.88 μg of diolein, 125 nmol of CaCl₂, 1.25 nmol of [γ-³²]ATP (5-10 × 10⁴ cpm/nmol) and 5 μg of partially purified enzyme. The binding of [³H]PDBu to protein kinase C is determined: Reaction mixture (200 μL contained 4 μmo1 of Tris/malate, pH 6.8, 20 μmol of KCl, 30 nmol of CaC1₂, 20 μg of phosphatidylserine, 5 μg of partially purified protein kinase C, 0.5% (final concentration) of DMSO,10 pmol of [³H]PDBu (l-3 × 10⁴ cpm/pmol) and 10 μL of various amounts of Staurosporine.
细胞实验：^[4]	- 合并 Cell lines: PC12 Concentrations: 溶于DMSO,终浓度为1 μM Incubation Time: ~32 小时 Method: 使用Staurosporine处理细胞32小时。细胞在4%多聚甲醛中混合，然后使用DNA结合染料Hoechst 33342染色。在荧光照明下观察细胞，测定凋亡细胞百分数。 (Only for Reference)
动物实验：^[2]	- 合并 Animal Models: 短暂局部贫血的雄性Mongolian沙鼠或雄性 Wistar大鼠 Dosages: ~10 ng Administration: 定向处理到海马双边CA₁子域 (Only for Reference)

参考文献

- 合并

溶解度 (25°C)

体外	DMSO	4 mg/mL (8.57 mM)
	Water	Insoluble
	Ethanol	Insoluble

* 溶解度检测是由Selleck技术部门检测的，可能会和文献中提供的溶解度有所差异，这是由于生产工艺和批次不同产生的正常现象。请按照顺序依次加入各个纯溶剂。

化学数据 Download Staurosporine (AM-2282) SDF

分子量	466.53
化学式	C₂₈H₂₆N₄O₃
CAS号	62996-74-1
储存条件	3年-20°C 粉状 2年-80°C 溶于溶剂
别名	Antibiotic AM-2282, STS

动物体内配方计算器 (澄清溶液)

第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量）

给药剂量

mg/kg

动物平均体重

每只动物给药体积

动物数量

只

第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系Selleck为您提供正确的澄清溶液配方）

% DMSO+ % + % Tween 80+ % ddH₂O

计算重置

计算结果:

工作液浓度： mg/ml；

DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，注：如该浓度超过该批次药物DMSO溶解度，请先联系Selleck）；

体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL ddH₂O，混匀澄清。

注意：1. 首先保证母液是澄清的；
2. 一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。

计算器

摩尔浓度计算器

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系，公式为:

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)

摩尔浓度计算公式

质量

浓度

体积

分子量
=

×

×

*在配置溶液时，请务必参考Selleck产品标签上、SDS / COA（可在Selleck的产品页面获得）批次特异的分子量使用本工具。

稀释计算器

用本工具协助配置特定浓度的溶液，使用的计算公式为：

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为: C1V1 = C2V2 ( 输入输出 )

C1

V1

C2

V2
×

=

×

在配置溶液时，请务必参考Selleck产品标签上、SDS / COA（可在Selleck的产品页面获得）批次特异的分子量使用本工具。.

连续稀释计算器方程

连续稀释
初始浓度:
稀释倍数:

计算结果

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):

分子量计算器

通过输入化合物的化学式来计算其分子量：

注：化学分子式大小写敏感。C10H16N2O2 c10h16n2o2

摩尔浓度计算器

质量	浓度	体积	分子量
=	×	×
计算

技术支持

在订购、运输、储存和使用我们的产品的任何阶段，您遇到的任何问题，均可以通过拨打我们的热线电话400-668-6834，或者技术支持邮箱tech@selleck.cn，直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题，请给我们留言。

研究领域

产品类型

定制您的化合物库

Staurosporine (AM-2282)

客户使用Selleck生产的Staurosporine (AM-2282)发表文献99篇：

产品安全说明书

Antineoplastic and Immunosuppressive Antibiotics抑制剂选择性比较

生物活性

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

参考文献

溶解度 (25°C)

化学数据 Download Staurosporine (AM-2282) SDF

动物体内配方计算器 (澄清溶液)

计算器

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)

摩尔浓度计算公式

稀释计算器

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

连续稀释计算器方程

连续稀释

计算结果

分子量计算器

总分子量：g/mol

摩尔浓度计算器

技术支持